What is a European small cap?
A small cap is a listed company with a low market capitalisation — conventionally between €50 million and €1 billion. Market capitalisation is simply the share price multiplied by the number of shares outstanding, so the label describes the size of the company as the market prices it, nothing more.
These boundaries are conventions, not definitions: every index provider applies its own thresholds, and a company can be a small cap on one classification and a mid cap on another. For a private investor the exact cut-off matters far less than the practical consequences of small size — liquidity, analyst coverage and volatility. Those are what change how you have to behave.
Where European small caps list
Small caps are concentrated on Europe's junior markets, which apply lighter admission and reporting requirements than the regulated markets:
| Venue | Scope | Regulation | Typical profile |
|---|---|---|---|
| Euronext Growth | Paris, Amsterdam, Brussels, Lisbon, Dublin, Oslo | Lighter — no full prospectus regime | Established SMEs, the deepest pool in the euro zone |
| Euronext Access | Same markets | Minimal — simple admission | Micro-caps, often very illiquid |
| AIM (London) | United Kingdom | Nominated adviser regime | The largest junior market in Europe by company count |
| Regulated markets | All European exchanges | Full regime | The larger small caps and mid caps |
A lighter regime is not a lighter risk. Junior markets exist to let smaller companies raise capital without the cost of the full regulated framework. The trade-off lands on the investor: fewer mandatory disclosures, less frequent reporting, and a greater need to read the accounts yourself.
Why the segment stays inefficient
The size effect — the long-run tendency of smaller companies to outperform larger ones — has been documented since Banz (1981). Several mechanisms sustain it:
- Coverage gap. A blue chip is followed by dozens of sell-side analysts; public information is priced within minutes. A company worth €80 million may have one analyst, or none. Prices can stay away from fundamentals for months.
- Liquidity premium. Investors demand extra expected return to hold assets they cannot exit quickly. That premium is a cost to the seller and a return to the patient holder.
- Room to grow. A €100 million company can plausibly double in five years. A €100 billion company cannot do the same thing arithmetically.
- Acquisition potential. Small caps are regularly bought by larger groups, usually at a control premium over the market price.
- Institutional constraints. Large funds often cannot build a meaningful position in a company this size without owning too much of it, so a whole category of buyer is structurally absent.
The effect is not a yearly entitlement. It is a statistical tendency measured over decades, and there are long stretches where it reverses — European small caps underperformed large caps through much of 2018–2022. Anyone using the size effect as an argument needs a horizon of at least five years, otherwise the argument does not apply to them.
The five risks that actually matter
Small caps carry risks that are different in kind, not just in degree, from those of large caps:
| Risk | What it looks like | How it is managed |
|---|---|---|
| Liquidity | Wide bid-ask spread; a few tens of thousands of euros traded a day. Selling in size moves the price against you. | Cap the size of each position; use limit orders, never market orders. |
| Information | Semi-annual reporting, sparse investor communication, almost no press coverage. | Read the annual report and the filings directly rather than waiting for a summary. |
| Concentration | Single product, single market, sometimes a single dominant client. One lost contract changes the case. | Hold at least ten to fifteen positions; check the revenue split before buying. |
| Governance | A founder or family often controls the majority. Minority interests can come second. | Check the shareholder structure and the history of past capital increases. |
| Volatility | Drawdowns of 30–50% in weeks, sometimes with no change in fundamentals. | Phase your entries, keep a long horizon, and use no leverage. |
None of these is a reason to avoid the segment. They are the reason the premium exists in the first place: an investor is paid for accepting constraints that larger investors will not accept.
How to screen the universe
With thousands of listed companies across European junior markets, reading annual reports one by one is not a strategy. A screen narrows the field first; analysis comes second. Four pillars do most of the work:
- Valuation. EV/EBITDA, P/E, price-to-book. A good business bought at the wrong price does not produce outperformance. Enterprise value is preferable to market cap alone when companies carry different levels of debt.
- Growth. Revenue and earnings progression over three to five years. Organic growth is worth more than growth bought through dilutive acquisitions.
- Financial strength. Net debt to EBITDA, current ratio, free cash flow generation. Fragile balance sheets are where small caps fail first when rates rise.
- Momentum. Price trend and estimate revisions. A fundamentally sound company in a sustained downtrend often keeps falling — the market may be seeing something the accounts do not yet show.
No single pillar is sufficient. A cheap company with deteriorating fundamentals is a value trap; an expensive one with strong momentum is a bet on the trend continuing. The point of combining them is to require a company to be defensible on several grounds at once.
Screener Small Caps covers the European, UK and US small-cap universe from public sources, with a composite score updated every evening.
Next steps: the Euronext Growth market guide, the European small-cap screener, and the glossary.